Literature DB >> 27009944

Bacterial Expression and HTS Assessment of Soluble Epoxide Hydrolase Phosphatase.

Franca-Maria Klingler1, Markus Wolf2, Sandra Wittmann1, Philip Gribbon2, Ewgenij Proschak3.   

Abstract

Soluble epoxide hydrolase (sEH) is a bifunctional enzyme that possesses an epoxide hydrolase and lipid phosphatase activity (sEH-P) at two distinct catalytic domains. While the physiological role of the epoxide hydrolase domain is well understood, the consequences of the phosphatase activity remain unclear. Herein we describe the bacterial expression of the recombinant N-terminal domain of sEH-P and the development of a high-throughput screening protocol using a sensitive and commercially available substrate fluorescein diphosphate. The usability of the assay system was demonstrated and novel inhibitors of sEH-P were identified.
© 2016 Society for Laboratory Automation and Screening.

Entities:  

Keywords:  enzyme assay; high-throughput screening; phosphatase; soluble epoxide hydrolase

Mesh:

Substances:

Year:  2016        PMID: 27009944     DOI: 10.1177/1087057116637609

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  4 in total

1.  Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.

Authors:  Jan S Kramer; Stefano Woltersdorf; Thomas Duflot; Kerstin Hiesinger; Felix F Lillich; Felix Knöll; Sandra K Wittmann; Franca-M Klingler; Steffen Brunst; Apirat Chaikuad; Christophe Morisseau; Bruce D Hammock; Carola Buccellati; Angelo Sala; G Enrico Rovati; Matthieu Leuillier; Sylvain Fraineau; Julie Rondeaux; Victor Hernandez-Olmos; Jan Heering; Daniel Merk; Denys Pogoryelov; Dieter Steinhilber; Stefan Knapp; Jeremy Bellien; Ewgenij Proschak
Journal:  J Med Chem       Date:  2019-09-17       Impact factor: 7.446

2.  Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase.

Authors:  Ulrike Garscha; Erik Romp; Simona Pace; Antonietta Rossi; Veronika Temml; Daniela Schuster; Stefanie König; Jana Gerstmeier; Stefanie Liening; Markus Werner; Heiner Atze; Sandra Wittmann; Christina Weinigel; Silke Rummler; Gerhard K Scriba; Lidia Sautebin; Oliver Werz
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

3.  Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast.

Authors:  Simone Schierle; Moritz Helmstädter; Jurema Schmidt; Markus Hartmann; Maximiliane Horz; Astrid Kaiser; Lilia Weizel; Pascal Heitel; Anna Proschak; Victor Hernandez-Olmos; Ewgenij Proschak; Daniel Merk
Journal:  ChemMedChem       Date:  2019-11-19       Impact factor: 3.466

4.  Development and in vitro Profiling of Dual FXR/LTA4H Modulators.

Authors:  Simone Schierle; Steffen Brunst; Moritz Helmstädter; Roland Ebert; Jan S Kramer; Dieter Steinhilber; Ewgenij Proschak; Daniel Merk
Journal:  ChemMedChem       Date:  2021-05-24       Impact factor: 3.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.